Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?

Stay connected! Follow us on X network (Twitter):

Share By

Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis? Publisher

Moghadasi AN¹ ; Anjidani N² ; Rashvand F³

Source: Frontiers in Emergency Medicine Published:2021

[No abstract available]

Style	Citing Format
MLA	Moghadasi AN, Anjidani N, Rashvand F. "Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?." Frontiers in Emergency Medicine, vol. 5, no. 3, 2021, pp. -.
APA	Moghadasi AN, Anjidani N, Rashvand F (2021). Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?. Frontiers in Emergency Medicine, 5(3), -.
Chicago	Moghadasi AN, Anjidani N, Rashvand F. "Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?." Frontiers in Emergency Medicine 5, no. 3 (2021): -.
Harvard	Moghadasi AN, Anjidani N, Rashvand F (2021) 'Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?', Frontiers in Emergency Medicine, 5(3), pp. -.
Vancouver	Moghadasi AN, Anjidani N, Rashvand F. Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?. Frontiers in Emergency Medicine. 2021;5(3):-.
BibTex	@article{ author = {Moghadasi AN and Anjidani N and Rashvand F}, title = {Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis?}, journal = {Frontiers in Emergency Medicine}, volume = {5}, number = {3}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Moghadasi AN AU - Anjidani N AU - Rashvand F TI - Could Fampridine Attenuate the Severity of Covid-19 in Patients With Multiple Sclerosis? JO - Frontiers in Emergency Medicine VL - 5 IS - 3 SP - EP - PY - 2021 ER -